Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Today prediction

<< Previous

Bullboard Posts

Next >>

Comment by PTBaileyon Jan 25, 2022 7:27pm

68 Views

Post# 34360447

RE:RE:Today prediction

"Some make it up as they go along ....then put in a disclaimer near the end like.....I head it somewhere or ...."to the best of my knowledge" ....or some other line....They don't know anything that we don't know...."

Some do and some don't. Some just say they were talking to Bob the other day and tell us what they talked about. You claim they are paid pumpers so if they're getting paid they must be told by Bob what to say so even you agree it's legit.

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale